Roundup Litigation: A Fight Against Monsanto

Introduction

Roundup, one of the world's most widely used herbicides, has become the center of one of the largest mass tort litigations in recent history. Manufactured by Monsanto (now owned by Bayer), Roundup contains glyphosate, a chemical that has been linked to non-Hodgkin lymphoma and other serious health conditions. This article examines the history of Roundup litigation, the scientific evidence behind the claims, and the landmark verdicts that have reshaped the landscape of corporate accountability in the agricultural industry.

The History of Roundup

Roundup was first introduced by Monsanto in 1974 and quickly became the most popular herbicide in the world. Its active ingredient, glyphosate, was praised for its effectiveness in killing weeds while being marketed as safe for humans and animals. For decades, Roundup was used extensively by farmers, landscapers, and homeowners alike. However, growing concerns about its safety began to emerge in the scientific community.

Health Concerns and Scientific Evidence

Research has increasingly linked glyphosate exposure to serious health issues:

• Non-Hodgkin Lymphoma: Multiple studies have found a significant association between glyphosate exposure and an increased risk of non-Hodgkin lymphoma, a type of blood cancer.
• IARC Classification: In 2015, the International Agency for Research on Cancer (IARC), a branch of the World Health Organization, classified glyphosate as "probably carcinogenic to humans."
• Genetic Damage: Studies have shown that glyphosate can cause DNA and chromosomal damage in human cells, raising concerns about its long-term effects.

The Allegations Against Monsanto

The central claims in Roundup litigation allege that Monsanto knew about the cancer risks associated with glyphosate but actively concealed this information from the public and regulators. Key allegations include:

• Suppression of Evidence: Plaintiffs allege that Monsanto suppressed internal research showing the potential dangers of glyphosate and influenced scientific studies to downplay risks.
• Ghostwriting Studies: Evidence emerged that Monsanto ghostwrote scientific papers and paid scientists to put their names on favorable studies about glyphosate safety.
• Regulatory Manipulation: It was alleged that Monsanto worked to influence regulatory agencies and discredit independent scientists who raised concerns about Roundup's safety.

Landmark Legal Battles

The Roundup litigation has produced some of the most significant verdicts against a major corporation in mass tort history. Thousands of plaintiffs across the United States have filed lawsuits claiming that their exposure to Roundup caused them to develop cancer.

Notable Verdicts and Settlements

• Johnson v. Monsanto (2018): In the first Roundup trial to go to verdict, a California jury awarded Dewayne Johnson, a former school groundskeeper with terminal non-Hodgkin lymphoma, $289 million in damages (later reduced to $78.5 million). The jury found that Monsanto acted with malice and knew Roundup posed health risks.
• Hardeman v. Monsanto (2019): A federal jury awarded Edwin Hardeman $80 million after finding that Roundup was a substantial factor in causing his non-Hodgkin lymphoma.
• Pilliod v. Monsanto (2019): A jury awarded Alva and Alberta Pilliod $2 billion in damages (later reduced), finding that Roundup caused both plaintiffs to develop non-Hodgkin lymphoma.
• Global Settlement: In 2020, Bayer announced a settlement of approximately $10.9 billion to resolve tens of thousands of Roundup claims, one of the largest product liability settlements in history.

Impact of Roundup Litigation

The Roundup litigation has had profound effects on corporate accountability and public awareness:

• Corporate Transparency: The litigation exposed internal documents showing how Monsanto prioritized profits over consumer safety and manipulated scientific discourse.
• Regulatory Scrutiny: The lawsuits have prompted increased scrutiny of pesticide regulations and the safety review processes used by regulatory agencies.
• Consumer Awareness: Public awareness of the potential risks associated with glyphosate has increased significantly, leading many consumers and governments to reconsider the use of Roundup.

Ongoing Litigation and Future Implications

Despite the multi-billion dollar settlement, Roundup litigation continues as new cases are filed and some plaintiffs opt out of the settlement. Bayer faces ongoing legal challenges and has announced plans to replace glyphosate in residential products while continuing to defend its safety in agricultural applications. The outcome of this litigation will have lasting implications for chemical manufacturers and the standards of corporate responsibility in the industry.

Conclusion

Roundup litigation stands as a powerful example of how the legal system can hold corporations accountable for concealing the dangers of their products. The verdicts and settlements in these cases have not only provided compensation to those harmed but have also exposed corporate practices that endangered public health. As the litigation continues, it serves as a reminder of the importance of transparency, scientific integrity, and the rights of individuals to seek justice against even the largest corporations.

Learn More

If you or a loved one has been diagnosed with non-Hodgkin lymphoma or another cancer after exposure to Roundup, there are resources available to help you understand your legal options. Many organizations provide support and information for those affected by pesticide-related illnesses. Seeking legal guidance can help you navigate the complex litigation process and pursue the compensation you may be entitled to.